✦ LIBER ✦

Antimycobacterial therapy for Crohn’s disease

✍ Scribed by Jacob Gilad

Book ID: 119389980
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 176 KB
Volume: 95
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(00)02008-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antimycobacterial therapy for Crohn's di

Antimycobacterial therapy for Crohn's disease: a reanalysis

✍ Marcel A Behr; James Hanley 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 66 KB

A meta-analysis of antimycobacterial the

A meta-analysis of antimycobacterial therapy for Crohn’s disease

✍ Mark R Borgaonkar; Donald G MacIntosh; John M Fardy 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

Controlled trial of antimycobacterial th

Controlled trial of antimycobacterial therapy in Crohn's disease

✍ N. H. Afdhal; A. Long; J. Lennon; J. Crowe; D. P. O'Donoghue 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 497 KB

Postoperative therapy for Crohn's diseas

Postoperative therapy for Crohn's disease

✍ Eric Blum; Jeffry A. Katz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Prevention of the postoperative recurrence of Crohn's disease (CD) remains a challenging clinical problem. The majority of patients with CD will need surgery for treatment of the disease, most of these patients will develop recurrent symptoms within 5 years postoperatively, and many patients will ne

Medical therapy for Crohn's disease stri

Medical therapy for Crohn's disease strictures

✍ Gert Van Assche; Karel Geboes; Paul Rutgeerts 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Infliximab therapy for fistulizing Crohn

Infliximab therapy for fistulizing Crohn’s disease

✍ Zafar Mirza; Emily Kosa; Saket Prasad; Louis Griffel; Kiron Das 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 30 KB